{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:44:27Z","timestamp":1784234667809,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Mental Health, Prescription Opioid Analgesics and Risk of Depression","award":["R21MH101389"],"award-info":[{"award-number":["R21MH101389"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ypmed.2016.08.003","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T08:45:15Z","timestamp":1470300315000},"page":"110-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["The influence of prescription opioid use duration and dose on development of treatment resistant depression"],"prefix":"10.1016","volume":"91","author":[{"given":"Jeffrey F.","family":"Scherrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. David","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen K.","family":"Bucholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Burroughs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurel","family":"Copeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Ahmedani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Lustman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2016.08.003_bb0005","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models","volume":"168","author":"Cole","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ypmed.2016.08.003_bb0010","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4088\/JCP.v63n0810","article-title":"Identification of a claims data \u2018signature\u2019 and economic consequences for treatment-resistant depression","volume":"63","author":"Corey-Lisle","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ypmed.2016.08.003_bb0015","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1097\/MLR.0b013e31806518ac","article-title":"Using inverse probability-weighted estimators in comparative effectiveness analysis with observational databases","volume":"45","author":"Curtis","year":"2007","journal-title":"Med. Care"},{"key":"10.1016\/j.ypmed.2016.08.003_bb0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jpain.2007.08.005","article-title":"Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain","volume":"9","author":"Daniell","year":"2008","journal-title":"J. Pain"},{"key":"10.1016\/j.ypmed.2016.08.003_bb0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the United States","volume":"372","author":"Dart","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2016.08.003_bb0030","series-title":"Medical and Psychiatric Comorbidity Over the Course of Life","author":"Eaton","year":"2006"},{"key":"10.1016\/j.ypmed.2016.08.003_bb0035","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0193-953X(05)70283-5","article-title":"Definition and epidemiology of treatment-resistant depression","volume":"19","author":"Fava","year":"1996","journal-title":"Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.ypmed.2016.08.003_bb0040","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1176\/appi.ajp.2015.15070921","article-title":"Opioid modulation with burprenorphine\/samidorphan as adjuntive treatment for inadequate response to antidepressants: a randomized double-blind placebo controlled trial","volume":"173","author":"Fava","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ypmed.2016.08.003_bb0045","series-title":"Depression and Heart Disease","author":"Glassman","year":"2011"},{"issue":"4","key":"10.1016\/j.ypmed.2016.08.003_bb0050","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1370\/afm.1371","article-title":"Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse","volume":"10","author":"Grattan","year":"2012","journal-title":"Ann. Fam. Med."},{"issue":"1","key":"10.1016\/j.ypmed.2016.08.003_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.genhosppsych.2013.10.003","article-title":"The missing \u2018P\u2019 in pain management: how the current opioid epidemic highlights the need for psychiatric services in chronic pain care","volume":"36","author":"Howe","year":"2014","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.ypmed.2016.08.003_bb0060","author":"Hygiene NYCDoHaM"},{"key":"10.1016\/j.ypmed.2016.08.003_bb0065","series-title":"The Use of Medicines in the United States: Review of 2010","year":"2011"},{"key":"10.1016\/j.ypmed.2016.08.003_bb0070","doi-asserted-by":"crossref","first-page":"e785","DOI":"10.4088\/JCP.13m08725","article-title":"Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults","volume":"75","author":"Karp","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ypmed.2016.08.003_bb0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/pds.3297","article-title":"Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rate treatment decisions","volume":"22","author":"Kilpatrick","year":"2013","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ypmed.2016.08.003_bb0080","doi-asserted-by":"crossref","first-page":"e76882","DOI":"10.1371\/journal.pone.0076882","article-title":"Characterization of treatment resistant depression episodes in a cohort of patients from a U.S. commercial claims database","volume":"8","author":"Kubitz","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ypmed.2016.08.003_bb0085","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/01.ajp.0000129757.31856.f7","article-title":"How pain and analgesics disturb sleep","volume":"21","author":"Onen","year":"2005","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.ypmed.2016.08.003_bb0090","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4088\/JCP.v65n0309","article-title":"The cost of treatment-resistant depression","volume":"65","author":"Russell","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ypmed.2016.08.003_bb0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1192\/bjp.bp.111.096479","article-title":"Treatment-resistant and insufficiently treated depresion and all-cause mortality following myocardial infarction","volume":"200","author":"Scherrer","year":"2012","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ypmed.2016.08.003_bb0100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1370\/afm.1885","article-title":"Prescription opioid duration, dose, and increased risk of depression in 3 large patient populations","volume":"14","author":"Scherrer","year":"2016","journal-title":"Ann. Fam. Med."},{"issue":"4","key":"10.1016\/j.ypmed.2016.08.003_bb0105","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jpain.2015.12.012","article-title":"Increased risk of depression recurrence after initiation of prescription opioids in noncancer pain patients","volume":"17","author":"Scherrer","year":"2016","journal-title":"J. Pain"},{"key":"10.1016\/j.ypmed.2016.08.003_bb0110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jpain.2015.12.012","article-title":"Increased risk of depression recurrence after initiation of prescription opioids in non-cancer pain patients","volume":"17","author":"Scherrer","year":"2016","journal-title":"J. Pain"},{"issue":"2","key":"10.1016\/j.ypmed.2016.08.003_bb0115","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/01.j.pain.0000460316.58110.a0","article-title":"Texas RRNo. Change in opioid dose and change in depression in a longitudinal primary care patient cohort","volume":"156","author":"Scherrer","year":"2015","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.ypmed.2016.08.003_bb0120","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11606-013-2648-1","article-title":"Prescription opioid analgesics increase the risk of depression","volume":"29","author":"Scherrer","year":"2014","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.ypmed.2016.08.003_bb0125","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/jama.2012.234","article-title":"Association of mental health disorders with prescription opioids and high-risk opioid use in US Veterans of Iraq and Afghanistan","volume":"307","author":"Seal","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ypmed.2016.08.003_bb0130","first-page":"ES145","article-title":"Opioid-induced androgen deficiency (OPIAD)","volume":"15","author":"Smith","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.ypmed.2016.08.003_bb9000","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jad.2015.05.049","article-title":"Factors associated with the development of depression in chronic non-cancer pain patients following the onset of opioid treatment for pain","volume":"184","author":"Smith","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ypmed.2016.08.003_bb0135","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/1062860606288243","article-title":"Are claims data accurate enough to identify patients for performance measures or quality improvement? The case of diabetes, heart disease and depression","volume":"21","author":"Solberg","year":"2006","journal-title":"Am. J. Med. Qual."},{"issue":"3","key":"10.1016\/j.ypmed.2016.08.003_bb0140","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.pain.2010.08.036","article-title":"Who gets high-dose opioid therapy for chronic non-cancer pain?","volume":"151","author":"Sullivan","year":"2010","journal-title":"Pain"},{"issue":"19","key":"10.1016\/j.ypmed.2016.08.003_bb0145","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1001\/archinte.166.19.2087","article-title":"Association between mental health disorders, problem drug use, and regular prescription opioid use","volume":"166","author":"Sullivan","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ypmed.2016.08.003_bb0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00426537","article-title":"Naloxone (Narcan) treatment in depression: clinical observations and effects on CSF endorphins and monoamine metabolites","volume":"54","author":"Terenius","year":"1977","journal-title":"Psychopharmacology"},{"issue":"Suppl. 13","key":"10.1016\/j.ypmed.2016.08.003_bb0155","first-page":"23","article-title":"When at first you don't succeed: sequential strategies for antidepressant nonresponders","volume":"58","author":"Thase","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ypmed.2016.08.003_bb0160","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Vos","year":"2015","journal-title":"Lancet"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743516302092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743516302092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T09:52:47Z","timestamp":1536486767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743516302092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":33,"alternative-id":["S0091743516302092"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2016.08.003","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The influence of prescription opioid use duration and dose on development of treatment resistant depression","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2016.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}